<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liang Z</submitter><funding>General Program of the National Natural Science Foundation of China</funding><funding>National Key R&amp;amp;D Program of China</funding><funding>Beijing Municipal Science and Technology Project</funding><funding>Changping laboratory</funding><pagination>e2261566</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10540657</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(2)</volume><pubmed_abstract>&lt;b>ABSTRACT&lt;/b>The global outbreak of COVID-19 has caused a severe threat to human health; therefore, simple, high-throughput neutralization assays are desirable for developing vaccines and drugs against COVID-19. In this study, a high-titre SARS-CoV-2 pseudovirus was successfully packaged by truncating the C-terminus of the SARS-CoV-2 spike protein by 21 amino acids and infecting 293 T cells that had been stably transfected with the angiotensin-converting enzyme 2 (ACE2) receptor and furin (named AF cells), to establish a simple, high-throughput, and automated 384-well plate neutralization assay. The method was optimized for cell amount, virus inoculation, incubation time, and detection time. The automated assay showed good sensitivity, accuracy, reproducibility, Z' factor, and a good cor</pubmed_abstract><journal>Emerging microbes &amp; infections</journal><pubmed_title>Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector.</pubmed_title><pmcid>PMC10540657</pmcid><funding_grant_id>82172244 &amp;amp; 32070678</funding_grant_id><funding_grant_id>Z211100002521018</funding_grant_id><funding_grant_id>2021YFC0863300</funding_grant_id><funding_grant_id>2021YFC2302500</funding_grant_id><funding_grant_id>2021YFC2301700</funding_grant_id><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Zhao C</pubmed_authors><pubmed_authors>Liang Z</pubmed_authors><pubmed_authors>Nie J</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Tong J</pubmed_authors><pubmed_authors>Qin H</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Lu Q</pubmed_authors><pubmed_authors>Wu X</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector.</name><description>&lt;b>ABSTRACT&lt;/b>The global outbreak of COVID-19 has caused a severe threat to human health; therefore, simple, high-throughput neutralization assays are desirable for developing vaccines and drugs against COVID-19. In this study, a high-titre SARS-CoV-2 pseudovirus was successfully packaged by truncating the C-terminus of the SARS-CoV-2 spike protein by 21 amino acids and infecting 293 T cells that had been stably transfected with the angiotensin-converting enzyme 2 (ACE2) receptor and furin (named AF cells), to establish a simple, high-throughput, and automated 384-well plate neutralization assay. The method was optimized for cell amount, virus inoculation, incubation time, and detection time. The automated assay showed good sensitivity, accuracy, reproducibility, Z' factor, and a good cor</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2026-05-29T01:58:01.725Z</modification><creation>2025-02-19T00:01:06.723Z</creation></dates><accession>S-EPMC10540657</accession><cross_references><pubmed>37727107</pubmed><doi>10.1080/22221751.2023.2261566</doi></cross_references></HashMap>